Endogenous DA-mediated feedback inhibition of DA neurons: Involvement of both D1- and D2-like receptors

Synapse

Volumn 35, Issue 2, 2000, Pages 111-119

  Shi, Wei Xing ^a   Pun, Chen Lun ^a   Smith, Paula L ^a   Bunney, Benjamin S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amphetamine; Basal ganglia; Dopamine; Globus pallidus; Parkinson's disease; Psychostimulant; SCH23390; Single unit recording; Striatum; Substantia nigra

Indexed keywords

DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEEDBACK SYSTEM; FOREBRAIN; MALE; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; DEXTROAMPHETAMINE; DOPAMINE; DOPAMINE ANTAGONISTS; FEEDBACK; MALE; NEURONS; PROSENCEPHALON; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SUBSTANTIA NIGRA;

EID: 0033987443     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(200002)35:2<111::AID-SYN3>3.0.CO;2-7     Document Type: Article

References (28)

1. 2 receptors with specific cellular elements in the basal ganglia of the cat: the uneven topography of dopamine receptors in the striatum is determined by intrinsic striatal cells, not nigrostriatal axons. Neuroscience 27:851-863.
2. Bunney BS, Aghajanian GK. 1976a. D-Amphetamine-induced inhibition of central dopaminergic neurons: mediation by a striato-nigral feedback pathway. Science 192:391-393.
3. Bunney BS, Aghajanian GK. 1976b. The precise localization of nigral afferents in the rat as determined by a retrograde tracing technique. Brain Res 117:423-435.
4. Bunney BS, Aghajanian GK. 1978. D-Amphetamine-induced depression of central dopamine neurons: evidence for mediation by both autoreceptors and a striato-nigral feedback pathway. Naunyn Schmiedebergs Arch Pharmacol 304:255-261.
5. Bunney BS, Walters JR, Roth RH, Aghajanian GK. 1973. Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther 185:560-571.
6. 1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons. Synapse 1:411-416.
7. 3 dopamine receptors in human striatum. Prog Neuropsychopharmacol Biol Psychiatry 19:1147-1154.
8. 2 receptors in MPTP-induced hemiparkinsonian monkeys. J Pharmacol Exp Ther 265:1387-1391 [erratum J Pharmacol Exp Ther 1993 267:566].
9. Gerfen CR. 1984. The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems. Nature 311:461-464.
10. Gerfen CR. 1985. The neostriatal mosaic. I. Compartmental organization of projections from the striatum to the substantia nigra in the rat. J Comp Neurol 236:454-476.
11. German DC, Manaye K, Smith WK, Woodward DJ, Saper CB. 1989. Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization [see comments]. Ann Neurol 26:507-514.
12. Grace AA, Bunney BS. 1980. Nigral dopamine neurons: intracellular recording and identification with L-dopa injection and histofluorescence. Science 210:654-556.
13. Grace AA, Bunney BS. 1983. Intracellular and extracellular electrophysiology of nigral dopaminergic neurons. 1. Identification and characterization. Neuroscience 10:301-315.
14. 1 receptors to striatonigral neurons. Brain Res 528:317-322.
15. Hattori T, Fibiger HC, McGeer PL. 1975. Demonstration of a pallidonigral projection innervating dopaminergic neurons. J Comp Neurol 162:487-504.
16. 1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists. J Pharmacol Exp Ther 260:409-416.
17. Huang KX, Bergstrom DA, Ruskin DN, Walters JR. 1998. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra. Synapse 30:18-29.
18. 2-mediated inhibition of nigrostriatal but not mesoaccumbens dopamine neurons. Synapse 2:416-423.
19. 2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J Comp Neurol 355:418-426.
20. 1 dopamine receptor gene. Proc Natl Acad Sci USA 88:4205-4209.
21. Ma SY, Roytta M, Rinne JO, Collan Y, Rinne UK. 1997. Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts. J Neurol Sci 151:83-87.
22. Pakkenberg B, Moller A, Gundersen HJ, Mouritzen Dam A, Pakkenberg H. 1991. The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. J Neurol Neurosurg Psychiatry 54:30-33.
23. 2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience 49:285-296.
24. 1 receptor selectivity and comparisons to the partial agonist SKF 38393. J Pharmacol Exp Ther 286:272-281.
25. 2 interaction in feedback control of midbrain dopamine neurons. J Neurosci 17:7988-7994.
26. 1 antagonist SCH23390. Soc Neurosci Abstr 19:78.
27. Sun BC, Huang KX, Jin GZ. 1993. Repeated reserpine treatment alters firing pattern and responses of substantia nigral dopamine neurons. Eur J Pharmacol 231:331-338.
28. Surmeier DJ, Song WJ, Yan Z. 1996. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J Neurosci 16:6579-6591.